Process for producing amine compounds

US9376372B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9376372-B2
Application numberUS-201314412633-A
CountryUS
Kind codeB2
Filing dateJul 8, 2013
Priority dateJul 6, 2012
Publication dateJun 28, 2016
Grant dateJun 28, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides processes for producing amine compounds. The amine compounds include diammonium compounds and amino acid derivatives.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for producing an amino acid salt or derivative thereof comprising the steps of: providing an unsaturated amine salt or derivative thereof; and wherein the unsaturated amine salt is a compound of Formula I wherein each R 1 is independently selected from the group consisting of H, optionally C 1 -C 12 alkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted C 2 -C 12 heteroalkyl, optionally substituted C 3 -C 12 cycloalkyl, optionally substituted C 3 -C 12 cycloalkenyl, optionally substituted C 2 -C 12 heterocycloalkyl, optionally substituted C 2 -C 12 heterocycloalkenyl, optionally substituted C 6 -C 18 aryl, optionally substituted C 1 -C 18 heteroaryl, optionally substituted C 1 -C 12 alkyloxy, optionally substituted C 2 -C 12 alkenyloxy, optionally substituted C 2 -C 12 alkynyloxy, optionally substituted C 2 -C 10 heteroalkyloxy, optionally substituted C 3 -C 12 cycloalkyloxy, optionally substituted C 3 -C 12 cycloalkenyloxy, optionally substituted C 2 -C 12 heterocycloalkyloxy, optionally substituted C 2 -C 12 heterocycloalkenyloxy, optionally substituted C 6 -C 18 aryloxy, optionally substituted C 1 -C 18 heteroaryloxy and optionally substituted C 1 -C 12 alkylamino; R 2 and R 3 are each independently selected from the group consisting of H and C 1 -C 12 alkyl; R 4 and R 5 are each independently selected from the group consisting of H, and C 1 -C 20 alkyl, n is an integer selected from the group consisting of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 and 20; X − is a counterion; and subjecting the unsaturated amine salt to cross-metathesis with a compound of Formula II wherein R 7 is selected from the group consisting of OH, OR 7a and NR 7a R 7b ; R 8 is selected from the group consisting of H and C 1 -C 12 alkyl; R 9 and R 10 are each independently selected from the group consisting of H, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl and C(═O)R 7 ; and R 7 and R 7b are each independently selected from the group consisting of H, optionally substituted C 1 -C 12 alkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted C 2 -C 12 heteroalkyl, optionally substituted C 3 -C 12 cycloalkyl, optionally substituted C 3 -C 12 cycloalkenyl, optionally substituted C 2 -C 12 heterocycloalkyl, optionally substituted C 2 -C 12 heterocycloalkenyl, optionally substituted C 6 -C 18 aryl, optionally substituted C 1 -C 18 heteroaryl, optionally substituted C 1 -C 12 alkyloxy, optionally substituted C 2 -C 12 alkenyloxy, optionally substituted C 2 -C 12 alkynyloxy, optionally substituted C 2 -C 10 heteroalkyloxy, optionally substituted C 3 -C 12 cycloalkyloxy, optionally substituted C 3 -C 12 cycloalkenyloxy, optionally substituted C 2 -C 12 heterocycloalkyloxy, optionally substituted C 2 -C 12 heterocycloalkenyloxy, optionally substituted C 6 -C 18 aryloxy, optionally substituted C 1 -C 18 heteroaryloxy and optionally substituted C 1 -C 12 alkylamino; in the presence of a metathesis catalyst to give the amino acid salt or derivative thereof. 2. The process according to claim 1 , wherein R 1 is H, R 2 is H and R 3 is H. 3. The process according to claim 1 , wherein n is selected from the group consisting of 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10. 4. The process according to claim 1 , wherein R 4 is H and R 5 is H. 5. The process according to claim 1 , wherein X − is selected from the group consisting of BF 4 − , TsO − , Cl − , TfO − , TFA − , Adipate 2− , BSA − , MsO − , HSO 4 − , F − , Br − , I − , H 2 AsO 4 − , H 2 PO 4 − , H 2 AsO 3 − , HPO 4 2− , H 2 PO 4 − , SO 4 2− , NO 3 − , NO 2 − , S 2 O 3 2− , HSO 3 − , ClO 4 − , IO 3 − , ClO 3 − , BrO 3 − , ClO 2 − , CrO 4 2− , HCO 3 − , Cr 2 O 7 2− , ClCH 2 COO − , HCOO − , OCN − , HC 2 O 4 − , B(OR) 4 − , B(OH) 4 − , CF 2 HSO 2 —O − , CFH 2 SO 2 —O − and alkyl aryl sulfonates. 6. The process according to claim 5 , wherein X − is selected from the group consisting of BF 4 − , TsO − and TfO − . 7. The process according to claim 1 , wherein R 7 is selected from the group consisting of OH and OC 1 -C 6 alkyl. 8. The process according to claim 1 , wherein R 8 is H, R 9 is H and R 10 is H. 9. The process according to claim 1 , wherein the compound of Formula II is a compound of Formula III wherein R 7 is selected from the group consisting of OH, OR 7a and NR 7a R 7b ; and R 7a and R 7b are each independently selected from the group consisting of H, optionally substituted C 1 -C 12 alkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted C 2 -C 12 heteroalkyl, optionally substituted C 3 -C 12 cycloalkyl, optionally substituted C 3 -C 12 cycloalkenyl, optionally substituted C 2 -C 12 heterocycloalkyl, optionally substituted C 2 -C 12 heterocycloalkenyl, optionally substituted C 6 -C 18 aryl, optionally substituted C 1 -C 18 heteroaryl, optionally substituted C 1 -C 12 alkyloxy, optionally substituted C 2 -C 12 alkenyloxy, optionally substituted C 2 -C 12 alkynyloxy, optionally substituted C 2 -C 10 heteroalkyloxy, optionally substituted C 3 -C 12 cycloalkyloxy, optionally substituted C 3 -C 12 cycloalkenyloxy, optionally substituted C 2 -C 12 heterocycloalkyloxy, optionally substituted C 2 -C 12 heterocycloalkenyloxy, optionally substituted C 6 -C 18 aryloxy, optionally substituted C 1 -C 18 heteroaryloxy and optionally substituted C 1 -C 12 alkylamino. 10. A process according to claim 1 , wherein the catalyst is a metal complex wherein the metal in the metal complex is selected from the group consisting of ruthenium, molybdenum and tungsten. 11. A process according to claim 1 , wherein the catalyst is a ruthenium-alkylidene catalyst, a Grubbs catalyst or a later generation analogue, or a Hoveyda Grubbs second generation catalyst. 12. The process according claim 1 , further comprising the step of hydrogenating the amino acid salt or derivative thereof; formed from cross-metathesis to give a saturated amino acid salt. 13. The process according to claim 12 , wherein the cross-metathesis step and the hydrogenating step are performed in series without isolation of the amino acid salt or derivative thereof; after cross-metathesis.

Assignees

Inventors

Classifications

  • Reduction · CPC title

  • C07C227/16Primary

    by reactions not involving the amino or carboxyl groups · CPC title

  • Preparation from compounds containing pyridine rings · CPC title

  • Isomerisation · CPC title

  • from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9376372B2 cover?
The present invention provides processes for producing amine compounds. The amine compounds include diammonium compounds and amino acid derivatives.
Who is the assignee on this patent?
Univ Monash
What technology area does this patent fall under?
Primary CPC classification C07C227/16. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).